US equities
|
SPCX
$167.58
▲+5.42%
NVDA
$237.19
▲+1.39%
MU
$1,065.27
▼-0.90%
TSLA
$377.90
▲+1.97%
MSFT
$525.36
▲+1.51%
SNDK
$1,708.72
▼-0.65%
INTC
$116.96
▼-1.99%
META
$743.96
▲+2.18%
SPCX
$167.58
▲+5.42%
NVDA
$237.19
▲+1.39%
MU
$1,065.27
▼-0.90%
TSLA
$377.90
▲+1.97%
MSFT
$525.36
▲+1.51%
SNDK
$1,708.72
▼-0.65%
INTC
$116.96
▼-1.99%
META
$743.96
▲+2.18%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cardiol Therapeutics Inc
(TSX:
CRDL
)
1.900
-0.130 (-6.40%)
Delayed Quote
Updated: 1:01 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cardiol Therapeutics Inc
< Previous
1
2
Next >
Tackling Recurring Health Conditions Offers Hope to Patients
June 21, 2022
Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly...
Via
FinancialNewsMedia
As Health Problems Mount Patients Welcome New Treatments
June 14, 2022
Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – There are several serious health problems facing society today. Some, like heart disease, gastrointestinal diseases, cancer,...
Via
FinancialNewsMedia
Breakthroughs In Treating Killer Diseases Could Lengthen Life
June 07, 2022
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal...
Via
FinancialNewsMedia
Topics
Death
Market Movers. Today’s Top Stock Picks For New & Trending Opportunities
May 27, 2022
Market Movers. Today's Top Stock Picks For New & Trending Opportunities
From
Stockhouse Publishing
Via
AccessWire
Why Orphan Drug Designation Offers Several Benefits
May 18, 2022
Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – The U.S. FDA prioritizes developing new treatments for rare diseases with the ability to grant Orphan Drug Designation. Here we...
Via
FinancialNewsMedia
Heart Failure Treatment Offers Hope to Diabetics
May 11, 2022
Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart...
Via
FinancialNewsMedia
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting
June 30, 2021
Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or...
Via
Newsfile
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT
June 28, 2021
Oakville, Ontario--(Newsfile Corp. - June 28, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...
Via
Newsfile
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development
June 15, 2021
Via
FinancialNewsMedia
Topics
Intellectual Property
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
April 28, 2021
Oakville, Ontario--(Newsfile Corp. - April 28, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...
Via
Newsfile
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)
April 12, 2021
Oakville, Ontario--(Newsfile Corp. - April 12, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...
Via
Newsfile
< Previous
1
2
Next >
